The money will go to the Gates Foundation.
Microsoft founder Bill Gates revealed that he will give away his wealth for various reasons ranging from climate adaptation to pandemic prevention. This will eventually cross his name off on the world’s richest people list.
With his wife, Gates started the Bill and Melinda Gates Foundation (BMGF) in 2000 to fight disease, poverty, and inequity around the world\.
Gates plans to donate most of his wealth to charitable causes carried out by his foundation in the future.
Physics World
Faster light is just one benefit of a new family of topological insulators.
In 1973, Paul Erdős asked if it was possible to assemble sets of “triples” — three points on a graph — so that they abide by two seemingly incompatible rules. A new proof shows it can always be done.
Sustainable cell cultured mollusk seafood products — nikita michelsen, founder & CEO, pearlita foods.
Nikita Michelsen, is Founder & CEO of Pearlita Foods (https://www.pearlitafoods.com/), the world’s first cell-based mollusk company, which is developing sustainably & ethically grown products, like oysters and abalone, that are contaminant free without compromising flavor or nutrition.
Most recently Nikita served as both Director of Community and Director of Marketing of SynBioBeta and their Built With Biology premier innovation network for biological engineers, innovators, entrepreneurs, and investors who share a passion for using biology to build a better, more sustainable planet.
Reimagining Nuclear Medicine — Dr. Stephen Moran, Ph.D., Global Program Head, Neuroendocrine Tumors & Other Radiosensitive Cancers, Advanced Accelerator Applications, Novartis
Dr. Stephen Moran, Ph.D., is Global Program Head, Neuroendocrine Tumors & Other Radiosensitive Cancers, for Advanced Accelerator Applications (AAA — https://www.adacap.com/), a Novartis company and also a member of the Oncology Development Unit Leadership Team at Novartis.
Prior to joining AAA, Dr. Moran was Global Head of Novartis Strategy, where he played a key role in defining the company’s strategy, prioritizing critical actions needed to deliver on the mission to discover new ways to extend and improve peoples’ lives. He also led numerous strategic initiatives, including gene therapy (AveXis, now Novartis Gene Therapies), RNA therapeutics (The Medicines Company), precision medicine and digital strategies.